首页> 外文学位 >Identification of membrane transporters to facilitate intranasal drug delivery using tissue-based and pharmacokinetic approaches.
【24h】

Identification of membrane transporters to facilitate intranasal drug delivery using tissue-based and pharmacokinetic approaches.

机译:使用基于组织和药代动力学的方法鉴定膜转运蛋白以利于鼻内药物输送。

获取原文
获取原文并翻译 | 示例

摘要

Nasal drug delivery has been broadly investigated in the past three decades. In addition to an effective therapeutic route for local illness, the nasal cavity presents a potential absorption site for systemic and direct CNS absorption. Since permeation of drug molecules across nasal membrane represents the rate limiting step in nasal absorption, especially for hydrophilic drug molecules, utilization and modification of membrane transporters located within nasal epithelium may facilitate absorption and enhance the bioavailability of drug compounds administered intranasally.;In vitro methods to evaluate drug transport mechanisms and concurrent metabolism are frequently used in pre-clinical drug development. These systems separate the permeation step from the following absorption cascades which occur in vivo, and allow the permeation step to be studied under well-controlled conditions. The permeability of various compounds across excised nasal mucosal tissues was studied, and linear, non-saturable and non-polarized flux was observed for cocaine and baclofen. In contrast, saturable and polarized flux was observed for L-phenylalanine. The presence of the large amino acid transporter system (LAT-1) was speculated to be responsible for L-phenylalanine uptake, and the transporter was further identified using immunohistochemistry and Western blotting techniques.;The systemic absorption of baclofen, an antispastic agent with a similar chemical structure to phenylalanine, was also investigated using in vivo absorption studies in rats. Baclofen was administered following intravenous and intranasal administration, and the resulting pharmacokinetic profile in the blood was studied. Similar pharmacokinetic profiles were observed between R- and S-baclofen following both intravenous and intranasal administration, and significant nasal absorption was observed for both enantiomers following nasal administration.;In an effort to use the permeability across excised nasal mucosal tissues to predict absorption, the cumulative nasal absorption was estimated for a number of nasally administered compounds using a deconvolution method. Correlation of the calculated absorption rate and measured permeation rate was attempted for nine small, hydrophilic compounds, and a close linear correlation was observed. These results suggest that the permeability obtained from in vitro studies can be used to predict nasal absorption and bioavailability following intranasal drug delivery.
机译:在过去的三十年中,已经广泛研究了鼻腔给药。除了针对局部疾病的有效治疗途径外,鼻腔还具有潜在的全身和直接中枢神经系统吸收部位。由于药物分子穿过鼻膜的渗透代表了鼻吸收的速率限制步骤,特别是对于亲水性药物分子而言,位于鼻上皮内的膜转运蛋白的利用和修饰可以促进鼻内给药的药物的吸收并提高其生物利用度。在临床前药物开发中经常使用评估药物转运机制和同时代谢的方法。这些系统将渗透步骤与随后的体内吸收级联分开,并允许在良好控制的条件下研究渗透步骤。研究了各种化合物在切除的鼻黏膜组织中的渗透性,并观察到可卡因和巴氯芬的线性,非饱和和非极化通量。相反,观察到L-苯丙氨酸的饱和和极化通量。推测大氨基酸转运蛋白系统(LAT-1)的存在是L-苯丙氨酸摄取的原因,并且通过免疫组织化学和Western印迹技术进一步鉴定了该转运蛋白。还使用大鼠体内吸收研究对与苯丙氨酸相似的化学结构进行了研究。在静脉内和鼻内给药后给予巴氯芬,并研究所得血液中的药代动力学特征。在静脉和鼻内给药后,R-和S-baclofen之间观察到相似的药代动力学特征,并且在鼻内给药后,两种对映异构体均观察到显着的鼻吸收。使用反卷积法估算了一些经鼻给药的化合物的累积鼻吸收。尝试将九种亲水性小化合物的计算吸收率与测得的渗透率进行关联,并观察到紧密的线性相关性。这些结果表明,从体外研究中获得的通透性可用于预测鼻内给药后鼻吸收和生物利用度。

著录项

  • 作者

    Zhang, Hefei.;

  • 作者单位

    The University of Iowa.;

  • 授予单位 The University of Iowa.;
  • 学科 Health Sciences Pharmacy.
  • 学位 Ph.D.
  • 年度 2009
  • 页码 179 p.
  • 总页数 179
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号